Trilogy International Partners (TSE:TRL) had its price target lowered by Scotiabank from C$9.50 to C$8.00 in a research note released on Friday. The firm currently has an outperform rating on the specialty pharmaceutical company’s stock.
Separately, TD Securities upgraded Trilogy International Partners from a hold rating to a buy rating and set a C$7.00 target price on the stock in a research note on Wednesday, March 7th.
Shares of Trilogy International Partners (TRL) opened at C$4.95 on Friday. Trilogy International Partners has a 52 week low of C$4.95 and a 52 week high of C$10.02. The firm has a market capitalization of $305.41 and a price-to-earnings ratio of -0.04.
ILLEGAL ACTIVITY WARNING: This piece was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3300817/trilogy-international-partners-trl-price-target-lowered-to-c8-00-at-scotiabank.html.
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
Receive News & Ratings for Trilogy International Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners and related companies with MarketBeat.com's FREE daily email newsletter.